Estevao C. Barcelos-Silva

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Identification of alterations of immunometabolism associated with Pompe disease.

Identification of alterations of immunometabolism associated with Pompe disease.

Journal: Cellular and molecular life sciences : CMLS
Published: August 20, 2025

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Journal: HemaSphere
Published: August 18, 2025

Rewriting the dendritic cell code in cancer-from subset identity to immunotherapeutic design.

Rewriting the dendritic cell code in cancer-from subset identity to immunotherapeutic design.

Journal: FEBS letters
Published: May 27, 2025

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.

Journal: Leukemia
Published: August 22, 2024

Amniotic fluid stem cell-derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model.

Amniotic fluid stem cell-derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model.

Journal: Journal of extracellular vesicles
Published: September 24, 2023

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Journal: Cancers
Published: May 26, 2023

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.

Journal: Frontiers in oncology
Published: May 10, 2023

Genetic variation in NOTCH1 is associated with overweight and obesity in Brazilian elderly.

Genetic variation in NOTCH1 is associated with overweight and obesity in Brazilian elderly.

Journal: Scientific reports
Published: February 20, 2023

Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Journal: British journal of haematology
Published: September 29, 2022

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

Journal: Cell death & disease
Published: January 17, 2022

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.

Journal: Frontiers in oncology
Published: February 16, 2021

Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.

Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 05, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026